Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

AEterna Zentaris Inc T.AEZ

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  AEZS

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women's health.
Price: $0.38 Volume: 213,700
Change: $-0.005 % Change: -1.30%
Day High/Low: 0.385/0.365 52 Week High/Low: 1.68/0.335
Last Traded: May 22, 2015 09:15 Transaction Volume: 1500
Open: 0.385 Previous Close: 0.385
Bid: 0.375 Ask: 0.39
Bid Size: 20500 Ask Size: 8500
Market Cap: 36.1m Shares Out: 94.9m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts

  • great buy

    0 stars

    Looks like seeking alpha article scared some people, I took the chance and loaded some shares at these low prices. Waiting for a quick...

    4 stars


  • RE:nice dilution today

    0 stars

    as tweeted, decent coin made. ps. playing with MM on TSX, lol. AEZS, stateside controls the swings. lol. cheers, dave.

    4 stars


  • nice dilution today

    0 stars

    for fun, see if can recover a nickel or a dim off of intraday low today. :) cheers, dave.

    4 stars


  • Canadian Class Action Investigation

    0 stars

    http://www.investigationcounsel.com/aeterna-zentaris-investigation/  AETERNA ZENTARIS INVESTIGATION Investigation Counsel P.C...

    0 stars


  • RE:RE:RE:RE:Resume trading

    0 stars

    they might do another reverse split to keep their naz listing...their horn of aplenty...never ending funding up to now has always been...

    4.5 stars